Please provide your email address to receive an email when new articles are posted on . The first issue is to decide between an ab interno vs. ab externo approach. When treating glaucoma patients, the ...

Please provide your email address to receive an email when new articles are posted on . Patients who underwent a modified 360° suture trabeculotomy demonstrated a lower mean postop IOP and needed ...

To determine the efficacy and safety of trabeculotomy in congenital glaucoma patients operated on within first 3 months of birth. The mean follow-up was 38.38±11.77 months (range 12–48 months). Mean ...

March 21, 2012 (New York City) — Using the Trabectome (NeoMedix) surgical device to perform ab interno trabeculotomies significantly reduces intraocular pressure (IOP), according to a study presented ...

To report the safety and efficacy of combined trabeculotomy and trabeculectomy (CTT) in advanced primary developmental glaucoma with corneal diameter 14 mm or more. A total of 74 (121 eyes) ...

Open angle glaucoma is a chronic condition associated with elevated intraocular pressure (IOP). Early stages are usually asymptomatic but as the condition progresses it leads to visual impairment and, ...

BOSTON — In patients with open-angle glaucoma undergoing cataract surgery, the placement of 2 trabecular micro-bypass stents (iStent, Glaukos Corp.) reduced hypotensive medication use and ...

Sight Sciences Inc. (NASDAQ:SGHT) on Tuesday announced that UnitedHealthcare has updated its Glaucoma Surgical Treatments policy to cover goniotomy, trabeculotomy, canaloplasty (ab interno), and ...

ALISO VIEJO, Calif.--(BUSINESS WIRE)--ViaLase, Inc., a clinical-stage medical technology company pioneering incision-free, laser-based solutions for glaucoma, today announced that the first patient ...

MENLO PARK, California, Dec 23, 2016 /PRNewswire/ -- Sight Sciences, Inc., a venture-backed, commercial-stage ophthalmic medical device company announced today that it has received Health Canada ...